All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.
Educational comparison context for RETA/CAG versus related compounds referenced in research literature. This is documentation for procurement literacy — not protocol or stacking guidance.
RETA/CAG profile
RETA/CAG is a VaultLabs dual lyophilized research blend of retatrutide (12.5 mg) and cagrilintide (2.5 mg) in a 15 mg catalog unit — not a dual-strength GLP-3 RT presentation.
Type: Dual-peptide research blend
vs related compound: retatrutide
See /research/retatrutide for independent encyclopedia documentation.
vs related compound: tirzepatide
See /research/tirzepatide for independent encyclopedia documentation.
vs related compound: semaglutide
See /research/semaglutide for independent encyclopedia documentation.
Comparison workflow
Use the peptide stack planner for educational multi-compound review: /tools/peptide-stack-planner
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.